Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | P4HTM | Q9NXG6 | 2/20 | 0.39 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CCR1 | P32246 | 1/20 | 0.37 |
| ▸ | CCR5 | P51681 | 1/20 | 0.37 |
| ▸ | CCR8 | P51685 | 1/20 | 0.37 |
| ▸ | METAP1 | P53582 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL19019639 | 0.98 | CA2 (0.48) | CA2CA1NPSR1ALDH1A1KDM4E | |
| SCHEMBL29539386 | 0.96 | CA2 (0.50) | CA2CA1NPSR1ALDH1A1KDM4E | |
| SCHEMBL5835237 | 0.96 | CA2 (0.50) | CA2CA1NPSR1ALDH1A1KDM4E | |
| Lithium SCHEMBL31194789 | 0.94 | CA2 (0.48) | CA2CA1NPSR1ALDH1A1KDM4E | |
| SCHEMBL14020760 | 0.88 | CA2 (0.47) | CA2CA1NPSR1ALDH1A1KDM4E | |
| SCHEMBL1204670 | 0.86 | CA1 (0.58) | CA2CA1NPSR1ALDH1A1KDM4E | |
| SCHEMBL30382826 | 0.84 | CA1 (0.44) | CA2CA1NPSR1ALDH1A1KDM4E | |
| SCHEMBL26023319 | 0.84 | CA2 (0.40) | CA2CA1NPSR1ALDH1A1KDM4E | |
| SCHEMBL25797623 | 0.81 | CA2 (0.48) | CA2CA1NPSR1ALDH1A1KDM4E | |
| SCHEMBL14020779 | 0.80 | CA1 (0.44) | CA2CA1NPSR1ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230292595-A1 | Organic Light Emitting Diode and Device Comprising the Same | NOVALED GMBH (DE) | 2023-09-14 | — | — | US | disclosed |
| US-20230292595-A1 | Organic Light Emitting Diode and Device Comprising the Same | NOVALED GMBH (DE) | 2023-09-14 | — | — | US | disclosed |
| US-20230270004-A1 | Organic Light Emitting Diode and Device Comprising the Same | NOVALED GMBH (DE) | 2023-08-24 | — | — | US | disclosed |
| US-20230270004-A1 | Organic Light Emitting Diode and Device Comprising the Same | NOVALED GMBH (DE) | 2023-08-24 | — | — | US | disclosed |
| US-10490754-B2 | Transition metal complexes with tripodal ligands and the use thereof in OLEDs | UDC IRELAND LIMITED (IE) | 2019-11-26 | — | — | US | disclosed |
| US-10490754-B2 | Transition metal complexes with tripodal ligands and the use thereof in OLEDs | UDC IRELAND LIMITED (IE) | 2019-11-26 | — | — | US | disclosed |
| EP-3184534-B1 | TRANSITION METAL COMPLEXES WITH TRIPODAL LIGANDS AND THE USE THEREOF IN OLEDS | UDC IRELAND LTD (IE) | 2019-08-14 | — | — | EP | disclosed |
| US-20170194576-A1 | Transition Metal Complexes with Tripodal Ligands and the Use Thereof in OLEDs | UDC IRELAND LIMITED (IE) | 2017-07-06 | — | — | US | disclosed |
| US-20170194576-A1 | Transition Metal Complexes with Tripodal Ligands and the Use Thereof in OLEDs | UDC IRELAND LIMITED (IE) | 2017-07-06 | — | — | US | disclosed |
| US-20170194576-A1 | Transition Metal Complexes with Tripodal Ligands and the Use Thereof in OLEDs | UDC IRELAND LIMITED (IE) | 2017-07-06 | — | — | US | disclosed |
| EP-3184534-A1 | TRANSITION METAL COMPLEXES WITH TRIPODAL LIGANDS AND THE USE THEREOF IN OLEDS | UDC Ireland Limited (IE) | 2017-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10490754-B2 | Transition metal complexes with tripodal ligands and the use thereof in OLEDs | TRPM2, OCIAD2, TRPM6 | CA2 1518/4885CA1 2967/4885NPSR1 1540/4885 |
| US-20170194576-A1 | Transition Metal Complexes with Tripodal Ligands and the Use Thereof in OLEDs | TRPM2, OCIAD2, TRPM6 | CA2 1518/4885CA1 2967/4885NPSR1 1540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.